Author:
Hahntow Ines N,Mairuhu Gideon,van Valkengoed Irene GM,Koopmans Richard P,Michel Martin C
Abstract
Abstract
Background
Genotype-phenotype association studies are typically based upon polymorphisms or haplotypes comprised of multiple polymorphisms within a single gene. It has been proposed that combinations of polymorphisms in distinct genes, which functionally impact the same phenotype, may have stronger phenotype associations than those within a single gene. We have tested this hypothesis using genes encoding components of the renin-angiotensin-aldosterone system and the high blood pressure phenotype.
Methods
Our analysis is based on 1379 participants of the cross-sectional SUNSET study randomly selected from the population register of Amsterdam. Each subject was genotyped for the angiotensinogen M235T, the angiotensin-converting enzyme insertion/deletion and the angiotensin II type 1 receptor A1166C polymorphism. The phenotype high blood pressure was defined either as a categorical variable comparing hypertension versus normotension as in most previous studies or as a continuous variable using systolic, diastolic and mean blood pressure in a multiple regression analysis with gender, ethnicity, age, body-mass-index and antihypertensive medication as covariates.
Results
Genotype-phenotype relationships were explored for each polymorphism in isolation and for double and triple polymorphism combinations. At the single polymorphism level, only the A allele of the angiotensin II type 1 receptor was associated with a high blood pressure phenotype. Using combinations of polymorphisms of two or all three genes did not yield stronger/more consistent associations.
Conclusions
We conclude that combinations of physiologically related polymorphisms of multiple genes, at least with regard to the renin-angiotensin-aldosterone system and the hypertensive phenotype, do not necessarily offer additional benefit in analyzing genotype/phenotype associations.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Cuppen E: Haplotype-based genetics in mice and rats. Trends Genet. 2005, 21: 318-322. 10.1016/j.tig.2005.03.010.
2. Muszkat M, Kurnik D, Solus J, Sofowara GG, Xie HG, Jiang L, McMunn C, Ihrie P, Harris JR, Dawson EP, et al: Variation in the a2B-adrenergic receptor gene (ADRA2B) and its relationship to vascular responses in vivo. Pharmacogenet Genomics. 2005, 15: 407-414. 10.1097/01213011-200506000-00006.
3. Soldner A, Spahn-Langguth H, Mutschler E: The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure. Pharmazie. 1996, 51: 783-799.
4. Ferrario CM, Strawn WB: Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006, 98: 121-128. 10.1016/j.amjcard.2006.01.059.
5. Rosskopf D, Schürks M, Rimmbach C, Schäfers R: Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol. 2007, 374: 429-469. 10.1007/s00210-007-0133-2.